These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 17430117

  • 1. Chronic immune activation underlies morbid obesity: is IDO a key player?
    Brandacher G, Hoeller E, Fuchs D, Weiss HG.
    Curr Drug Metab; 2007 Apr; 8(3):289-95. PubMed ID: 17430117
    [Abstract] [Full Text] [Related]

  • 2. Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients.
    Brandacher G, Winkler C, Aigner F, Schwelberger H, Schroecksnadel K, Margreiter R, Fuchs D, Weiss HG.
    Obes Surg; 2006 May; 16(5):541-8. PubMed ID: 16687019
    [Abstract] [Full Text] [Related]

  • 3. The Interactions Between Kynurenine, Folate, Methionine and Pteridine Pathways in Obesity.
    Engin AB, Engin A.
    Adv Exp Med Biol; 2017 May; 960():511-527. PubMed ID: 28585214
    [Abstract] [Full Text] [Related]

  • 4. Tryptophan Metabolism in Obesity: The Indoleamine 2,3-Dioxygenase-1 Activity and Therapeutic Options.
    Engin AB, Engin A.
    Adv Exp Med Biol; 2024 May; 1460():629-655. PubMed ID: 39287867
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
    Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr 29; 35(3):702-21. PubMed ID: 21185346
    [Abstract] [Full Text] [Related]

  • 7. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
    Maes M, Mihaylova I, Ruyter MD, Kubera M, Bosmans E.
    Neuro Endocrinol Lett; 2007 Dec 29; 28(6):826-31. PubMed ID: 18063923
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Monitoring tryptophan metabolism in chronic immune activation.
    Schröcksnadel K, Wirleitner B, Winkler C, Fuchs D.
    Clin Chim Acta; 2006 Feb 29; 364(1-2):82-90. PubMed ID: 16139256
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity.
    Chaves Filho AJM, Lima CNC, Vasconcelos SMM, de Lucena DF, Maes M, Macedo D.
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan 03; 80(Pt C):234-249. PubMed ID: 28595944
    [Abstract] [Full Text] [Related]

  • 12. Kynurenine pathway metabolism and immune activation: Peripheral measurements in psychiatric and co-morbid conditions.
    Strasser B, Becker K, Fuchs D, Gostner JM.
    Neuropharmacology; 2017 Jan 03; 112(Pt B):286-296. PubMed ID: 26924709
    [Abstract] [Full Text] [Related]

  • 13. Indoleamine-2,3-Dioxygenase/Kynurenine Pathway as a Potential Pharmacological Target to Treat Depression Associated with Diabetes.
    da Silva Dias IC, Carabelli B, Ishii DK, de Morais H, de Carvalho MC, Rizzo de Souza LE, Zanata SM, Brandão ML, Cunha TM, Ferraz AC, Cunha JM, Zanoveli JM.
    Mol Neurobiol; 2016 Dec 03; 53(10):6997-7009. PubMed ID: 26671617
    [Abstract] [Full Text] [Related]

  • 14. Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
    Zamanakou M, Germenis AE, Karanikas V.
    Immunol Lett; 2007 Aug 15; 111(2):69-75. PubMed ID: 17644189
    [Abstract] [Full Text] [Related]

  • 15. Anxiety Disorders: Sex Differences in Serotonin and Tryptophan Metabolism.
    Songtachalert T, Roomruangwong C, Carvalho AF, Bourin M, Maes M.
    Curr Top Med Chem; 2018 Aug 15; 18(19):1704-1715. PubMed ID: 30430940
    [Abstract] [Full Text] [Related]

  • 16. Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.
    Oxenkrug GF.
    Ann N Y Acad Sci; 2007 Dec 15; 1122():35-49. PubMed ID: 18077563
    [Abstract] [Full Text] [Related]

  • 17. Tryptophan Metabolism Is Associated with BMI and Adipose Tissue Mass and Linked to Metabolic Disease in Pediatric Obesity.
    Lischka J, Schanzer A, Baumgartner M, de Gier C, Greber-Platzer S, Zeyda M.
    Nutrients; 2022 Jan 11; 14(2):. PubMed ID: 35057467
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice.
    Szántó S, Koreny T, Mikecz K, Glant TT, Szekanecz Z, Varga J.
    Arthritis Res Ther; 2007 Jan 11; 9(3):R50. PubMed ID: 17511858
    [Abstract] [Full Text] [Related]

  • 19. Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis.
    Criado G, Simelyte E, Inglis JJ, Essex D, Williams RO.
    Arthritis Rheum; 2009 May 11; 60(5):1342-51. PubMed ID: 19404944
    [Abstract] [Full Text] [Related]

  • 20. Peripheral kynurenine/tryptophan ratio is not a reliable marker of systemic indoleamine 2,3-dioxygenase: A lesson drawn from patients on hemodialysis.
    Chen Y, Xie Z, Xiao C, Zhang M, Li Z, Xie J, Zhang Y, Zhao X, Zeng P, Mo L, Liang X, Shi W.
    Oncotarget; 2017 Apr 11; 8(15):25261-25269. PubMed ID: 28445957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.